July 7-10, 2026 | Geneva
Dr. Alex Aliper, co-founder and president of Insilico Medicine, will be attending the AI for Good Global Summit 2026 on July 7 in Geneva, Switzerland. He will participate in a panel discussion titled “AI for Good Global Summit 2026.” “Expanding medical access through AI-powered science” From 14:30 to 15:00. After this, from 3:30 p.m. “Generative AI for drug discovery and pharmaceutical research and development” At the summit workshop: “AI for Manufacturing: Pharmaceutical Industry Workshop on Innovation, Applications and Standards”
About the AI for Good Global Summit
Organized by the International Telecommunication Union (ITU) in collaboration with numerous UN agencies, the summit serves as the world’s leading platform for AI-driven innovation. In close alignment with the United Nations’ Sustainable Development Goals (SDGs), this year’s summit will bring together leading scientists, industry leaders, and policy makers from around the world to explore the cross-cutting convergence of cutting-edge fields such as generative AI, pharmaceutical R&D, and smart manufacturing.
The summit is not only dedicated to showcasing breakthrough AI applications aimed at tackling global health disparities and accelerating the green transition, but also has the important mission of shaping global AI governance, safety frameworks, and technology standards. Through cross-border action and cooperation, this event aims to transform artificial intelligence into a powerful beacon to guide human society towards a fair, healthy and sustainable future.
July 8, 2026 | Beijing
Dr. Feng Ren, Co-CEO and Chief Scientific Officer of Insilico Medicine, is invited to deliver a keynote speech titled “From technological breakthrough to clinical validation: The second half of AI drug discovery” at the CITICS Global Consumer and Healthcare Forum 2026 in Beijing on July 8th.
In the face of intensifying disease challenges, the traditional trial-and-error R&D model has hit a bottleneck. Insilico Medicine is at the forefront of this transformation, leveraging our end-to-end Pharma.AI platform. The company’s diverse pipeline, driven by continuous innovation, currently includes more than 40 projects discovered by the Pharma.AI platform. Since 2021, Insilico has nominated 31 Developmental Candidates (DCs) and more than 10 projects have received Investigational New Drug (IND) approval.
The lead clinical-stage program is lentsertib (ISM001-055), an AI-discovered, AI-designed TNIK inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF), which recently achieved positive top-line results in a Phase IIa clinical trial. At the same time, the company is advancing several other programs into Phase I clinical development.
About CITICS Global Consumer and Healthcare Forum 2026
CITICS Global Consumer and Healthcare Forum 2026 is a major annual industry event hosted by CITIC Securities. This year’s forum will focus on the major transformation of China’s consumer market and the revolutionary changes in the healthcare industry due to breakthroughs in life sciences. The event brings together the world’s top business executives, industry experts, policy makers, and institutional investors from domestic and international markets.
In the consumer sector, the forum provides an in-depth analysis of new market conditions centered around quality upgrades and personalized demands. In healthcare, we comprehensively examine the reassessment of value across industry chains driven by innovative medicines and devices, diversified payment models, and enhanced AI. Against the backdrop of the current complex macroeconomic environment and the rotation of defensive sectors in global capital markets, this forum is dedicated to building an efficient and cutting-edge platform for dialogue. We aim to collaboratively uncover structural growth opportunities in both the Chinese and global markets and provide global investors with accurate strategic insights to capture long-term value in the consumer and healthcare sectors of the future.
July 8-10, 2026 | Hong Kong
Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, has been invited to attend LEAP EAST, an international science, technology and information technology exhibition in Hong Kong from July 8th to 10th. He will highlight the company’s latest advances in AI-driven drug discovery, quantum-enabled research, and clinical development through four key presentations.
The four noteworthy sessions are:
HSBC Innovation Banking x Betatron Breakfast Panel
time: July 8th, 8am-10am
position: HSBC main building
Panel discussion: Where is Asia’s next AI unicorn hiding?
time: July 8th, 11:30 a.m. to 12:00 p.m.
position: DeepFest – Leap East
Keynote: Tech for Healthcare: How AI is revolutionizing drug discovery
time: July 9th, 11:50am – 12:05pm
position: biotechnology orbital stage
Panel: Biological OS: How AI is deciphering life and longevity
time: July 9th, 2:45pm – 3:20pm
position: main stage
About LEAP East
LEAP East 2026 is Asia’s leading technology event, run by the core team behind LEAP, Saudi Arabia’s most influential global technology platform, and jointly supported by prestigious institutions including the Hong Kong Special Administrative Region Government Department of Innovation, Technology and Industry. The summit, to be held at the Hong Kong Convention and Exhibition Center from 8 to 10 July 2026, will leverage Hong Kong’s unique position as an international financial hub and vibrant multicultural ecosystem to create a brand new borderless technology hub that connects the world.
The conference focuses on cutting-edge areas such as generative AI, biomedical technology, smart manufacturing, fintech, and Web3, and brings together over 300 leading global exhibitors in addition to world-renowned scientists, tech giants, startups, and top investment institutions. LEAP East is more than just a technology showcase of disruptive deep technology and its applications. It is a catalyst for cross-border collaboration and a high-impact platform that facilitates business growth and capital matching. Ultimately, we aim to transform cutting-edge technology into a powerful force that propels global society toward a fair, healthy, and sustainable future.
